Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 2
1971 1
1972 4
1973 4
1974 3
1975 3
1976 8
1977 6
1978 4
1979 7
1980 8
1981 8
1982 12
1983 13
1984 9
1985 20
1986 11
1987 17
1988 13
1989 38
1990 32
1991 36
1992 33
1993 28
1994 28
1995 21
1996 34
1997 45
1998 42
1999 50
2000 39
2001 62
2002 47
2003 50
2004 63
2005 81
2006 104
2007 80
2008 97
2009 95
2010 92
2011 127
2012 133
2013 123
2014 141
2015 138
2016 140
2017 184
2018 185
2019 214
2020 189
2021 142
2022 82
2023 99
2024 80

Search Results

2,939 results

Results by year

Filters applied: . Clear all
Page 1
What's New in Topicals for Atopic Dermatitis?
Kleinman E, Laborada J, Metterle L, Eichenfield LF. Kleinman E, et al. Am J Clin Dermatol. 2022 Sep;23(5):595-603. doi: 10.1007/s40257-022-00712-0. Epub 2022 Sep 1. Am J Clin Dermatol. 2022. PMID: 36048410 Free PMC article. Review.
Recent Advancements in the Atopic Dermatitis Mechanism.
Savva M, Papadopoulos NG, Gregoriou S, Katsarou S, Papapostolou N, Makris M, Xepapadaki P. Savva M, et al. Front Biosci (Landmark Ed). 2024 Feb 22;29(2):84. doi: 10.31083/j.fbl2902084. Front Biosci (Landmark Ed). 2024. PMID: 38420827 Free article. Review.
Challenges and Future Trends in Atopic Dermatitis.
Gatmaitan JG, Lee JH. Gatmaitan JG, et al. Int J Mol Sci. 2023 Jul 12;24(14):11380. doi: 10.3390/ijms241411380. Int J Mol Sci. 2023. PMID: 37511138 Free PMC article. Review.
Atopic dermatitis.
Weidinger S, Novak N. Weidinger S, et al. Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X. Epub 2015 Sep 13. Lancet. 2016. PMID: 26377142 Review.
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.
Reich K, Thyssen JP, Blauvelt A, Eyerich K, Soong W, Rice ZP, Hong HC, Katoh N, Valenzuela F, DiBonaventura M, Bratt TA, Zhang F, Clibborn C, Rojo R, Valdez H, Kerkmann U. Reich K, et al. Lancet. 2022 Jul 23;400(10348):273-282. doi: 10.1016/S0140-6736(22)01199-0. Lancet. 2022. PMID: 35871814 Clinical Trial.
2,939 results